We are live on ! Find out more
NME

Notis-McConarty Edward Portfolio holdings

AUM $201M
1-Year Est. Return 18.67%
This Fund
S&P 500
This Quarter Est. Return
+3.77%
1 Year Est. Return
+18.67%
3 Year Est. Return
+65.19%
5 Year Est. Return
+89.79%
10 Year Est. Return
+322.21%
AUM
$254M
AUM Growth
+$1.44M
Cap. Flow
-$4.03M
Cap. Flow %
-1.58%
Top 10 Hldgs %
41.46%
Holding
92
New
3
Increased
8
Reduced
56
Closed
2

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.07M
2
BALL icon
Ball Corp
BALL
+$1.04M
3
CARR icon
Carrier Global
CARR
+$980K
4
MKC icon
McCormick & Company Non-Voting
MKC
+$797K
5
WMT icon
Walmart Inc
WMT
+$208K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$1.34M
2
NKE icon
Nike
NKE
+$1.16M
3
NVDA icon
NVIDIA
NVDA
+$1.08M
4
AMD icon
Advanced Micro Devices
AMD
+$333K
5
CVS icon
CVS Health
CVS
+$291K

Sector Composition

Rank Sector Weight
1 Technology 31.77%
2 Healthcare 19.93%
3 Industrials 12.8%
4 Consumer Discretionary 9.06%
5 Consumer Staples 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNP icon
51
Union Pacific
UNP
$178B
$968K 0.38%
4,280
-10
-0.2% -$2.34K
HON icon
52
Honeywell
HON
$77.9B
$964K 0.38%
4,790
-902
-16% -$172K
NKE icon
53
Nike
NKE
$62.5B
$950K 0.37%
12,601
-12,535
-50% -$1.16M
WM icon
54
Waste Management
WM
$95.5B
$827K 0.32%
3,875
– –
MKC icon
55
McCormick & Company Non-Voting
MKC
$13.6B
$776K 0.31%
+10,945
New +$797K
CSCO icon
56
Cisco
CSCO
$452B
$743K 0.29%
15,629
-600
-4% -$28.5K
IWB icon
57
iShares Russell 1000 ETF
IWB
$47.7B
$729K 0.29%
2,450
-200
-8% -$57.4K
MCD icon
58
McDonald's
MCD
$192B
$609K 0.24%
2,390
– –
INTC icon
59
Intel
INTC
$462B
$595K 0.23%
19,200
-1,300
-6% -$42.6K
OKE icon
60
Oneok
OKE
$56.4B
$575K 0.23%
7,056
– –
IR icon
61
Ingersoll Rand
IR
$33.1B
$561K 0.22%
6,176
– –
J icon
62
Jacobs Solutions
J
$16B
$559K 0.22%
4,836
– –
KO icon
63
Coca-Cola
KO
$362B
$494K 0.19%
7,760
-540
-7% -$33.4K
YUM icon
64
Yum! Brands
YUM
$40.7B
$483K 0.19%
3,650
– –
CI icon
65
Cigna
CI
$77B
$463K 0.18%
1,400
-50
-3% -$17.2K
CL icon
66
Colgate-Palmolive
CL
$73.6B
$404K 0.16%
4,165
-265
-6% -$24.4K
BMY icon
67
Bristol-Myers Squibb
BMY
$128B
$388K 0.15%
9,335
-800
-8% -$35.8K
DEO icon
68
Diageo
DEO
$47.3B
$378K 0.15%
3,000
-1,150
-28% -$158K
NVO
69
Novo Nordisk
NVO
$220B
$371K 0.15%
2,600
-400
-13% -$53K
EOG icon
70
EOG Resources
EOG
$74.7B
$362K 0.14%
2,875
– –
GILD icon
71
Gilead Sciences
GILD
$162B
$350K 0.14%
5,100
– –
SBUX icon
72
Starbucks
SBUX
$118B
$332K 0.13%
4,262
-585
-12% -$47.6K
TXN icon
73
Texas Instruments
TXN
$255B
$329K 0.13%
1,690
– –
SYY icon
74
Sysco
SYY
$40.2B
$309K 0.12%
4,332
-195
-4% -$14.6K
PBA icon
75
Pembina Pipeline
PBA
$29B
$297K 0.12%
8,000
-2,550
-24% -$92.2K
1 2
3
4

Similar funds

SIA
Spectrum Investment Advisors Mequon, Wisconsin $201M AUM 15.42% 1-Year Est. Return
LS
LCW Services Virginia Beach, Virginia $201M AUM
ACM
Ategra Capital Management Vienna, Virginia $201M AUM 23.33% 1-Year Est. Return
FB
First Bancorp Damariscotta, Maine $201M AUM 21.27% 1-Year Est. Return
MPM
Mountaineer Partners Management New York $201M AUM 106.11% 1-Year Est. Return
LWMI
Legacy Wealth Management (Idaho) Boise, Idaho $201M AUM 259.85% 1-Year Est. Return
RCM
Ridgepath Capital Management Knoxville, Tennessee $201M AUM 10.5% 1-Year Est. Return
CIG
Cairn Investment Group Vancouver, Washington $201M AUM 18% 1-Year Est. Return

Notis-McConarty Edward's Q2 2024 Portfolio in Review

As of Q2 2024, Notis-McConarty Edward held 92 positions worth $254M, up 0.57% from $253M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Notis-McConarty Edward's Q2 2024 filing shows 3 new, 8 increased, 56 reduced and 2 closed positions. Its largest new stake was McCormick & Company Non-Voting: 10,945 shares worth $776K. The largest sale was Novartis, an estimated $1.34M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.

  • Notis-McConarty Edward's largest Q2 2024 buy was McCormick & Company Non-Voting: 10,945 shares worth $776K.
  • Notis-McConarty Edward added most to Vertex Pharmaceuticals in Q2 2024, an estimated $1.07M increase.
  • Notis-McConarty Edward's biggest Q2 2024 reduction was Novartis, cutting an estimated $1.34M.
  • Notis-McConarty Edward fully exited Eli Lilly in Q2 2024, selling an estimated $272K.
  • Notis-McConarty Edward's ten largest holdings make up 41% of its $254M portfolio in Q2 2024.
  • Notis-McConarty Edward opened 3 new positions and closed 2 in Q2 2024.
  • Notis-McConarty Edward's portfolio value rose 0.57% quarter-over-quarter to $254M.

Based on Notis-McConarty Edward's 13F filing for Q2 2024, filed 12 Aug 2024.